Literature DB >> 20015984

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.

Gretja Schnell1, Richard W Price, Ronald Swanstrom, Serena Spudich.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is a severe neurological disease that affects a subset of HIV-1-infected individuals. Increased compartmentalization has been reported between blood and cerebrospinal fluid (CSF) HIV-1 populations in subjects with HAD, but it is still not known when compartmentalization arises during the course of infection. To assess HIV-1 genetic compartmentalization early during infection, we compared HIV-1 populations in the peripheral blood and CSF in 11 primary infection subjects, with analysis of longitudinal samples over the first 18 months for a subset of subjects. We used heteroduplex tracking assays targeting the variable regions of env and single-genome amplification and sequence analysis of the full-length env gene to identify CSF-compartmentalized variants and to examine viral genotypes within the compartmentalized populations. For most subjects, HIV-1 populations were equilibrated between the blood and CSF compartments. However, compartmentalized HIV-1 populations were detected in the CSF of three primary infection subjects, and longitudinal analysis of one subject revealed that compartmentalization during primary HIV-1 infection was resolved. Clonal amplification of specific HIV-1 variants was identified in the CSF population of one primary infection subject. Our data show that compartmentalization can occur in the central nervous system (CNS) of subjects in primary HIV-1 infection in part through persistence of the putative transmitted parental variant or via viral genetic adaptation to the CNS environment. The presence of distinct HIV-1 populations in the CSF indicates that independent HIV-1 replication can occur in the CNS, even early after HIV-1 transmission.

Entities:  

Mesh:

Year:  2009        PMID: 20015984      PMCID: PMC2820937          DOI: 10.1128/JVI.01863-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.

Authors:  J A Nelson; S A Fiscus; R Swanstrom
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  HIV-1 populations in blood and breast milk are similar.

Authors:  Gavin J Henderson; Noah G Hoffman; Li Hua Ping; Susan A Fiscus; Irving F Hoffman; Kathryn M Kitrinos; Topia Banda; Francis E A Martinson; Peter N Kazembe; David A Chilongozi; Myron S Cohen; Ronald Swanstrom
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

3.  Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.

Authors:  K Takahashi; S L Wesselingh; D E Griffin; J C McArthur; R T Johnson; J D Glass
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

4.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

Authors:  J J Sevigny; S M Albert; M P McDermott; J C McArthur; N Sacktor; K Conant; G Schifitto; O A Selnes; Y Stern; D R McClernon; D Palumbo; K Kieburtz; G Riggs; B Cohen; L G Epstein; K Marder
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

5.  Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.

Authors:  C Martin; J Albert; P Hansson; P Pehrsson; H Link; A Sönnerborg
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-03-01

Review 6.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

7.  Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation.

Authors:  J H Lane; V G Sasseville; M O Smith; P Vogel; D R Pauley; M P Heyes; A A Lackner
Journal:  J Neurovirol       Date:  1996-12       Impact factor: 2.643

8.  Human immunodeficiency virus type 1 populations in blood and semen.

Authors:  E L Delwart; J I Mullins; P Gupta; G H Learn; M Holodniy; D Katzenstein; B D Walker; M K Singh
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.

Authors:  P Cinque; L Vago; M Mengozzi; V Torri; D Ceresa; E Vicenzi; P Transidico; A Vagani; S Sozzani; A Mantovani; A Lazzarin; G Poli
Journal:  AIDS       Date:  1998-07-30       Impact factor: 4.177

10.  Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.

Authors:  W Kelder; J C McArthur; T Nance-Sproson; D McClernon; D E Griffin
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  103 in total

Review 1.  Eradication of human immunodeficiency virus from brain reservoirs.

Authors:  Avindra Nath
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

Review 2.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  Analysis of Dominant HIV Quasispecies Suggests Independent Viral Evolution Within Spinal Granulomas Coinfected with Mycobacterium tuberculosis and HIV-1 Subtype C.

Authors:  Sivapragashini Danaviah; Tulio de Oliveira; Michelle Gordon; Shunmugam Govender; Paul Chelule; Sureshnee Pillay; Thajasvarie Naicker; Sharon Cassol; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-17       Impact factor: 2.205

4.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

5.  Alterations in brain metabolism during the first year of HIV infection.

Authors:  Margaret R Lentz; Woong-Ki Kim; Hyun Kim; Caroline Soulas; Vallent Lee; Nagagopal Venna; Elkan F Halpern; Eric S Rosenberg; Kenneth Williams; R G González
Journal:  J Neurovirol       Date:  2011-04-15       Impact factor: 2.643

6.  Epigenetic regulation of HIV-1 latency in astrocytes.

Authors:  Srinivas D Narasipura; Stephanie Kim; Lena Al-Harthi
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 7.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

8.  Individuals with HIV-1 Subtype C Infection and Cryptococcal Meningitis Exhibit Viral Genetic Intermixing of HIV-1 Between Plasma and Cerebrospinal Fluid and a High Prevalence of CXCR4-Using Variants.

Authors:  Katlego Sojane; Richard T Kangethe; Christina C Chang; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-23       Impact factor: 2.205

Review 9.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.

Authors:  Maria M Bednar; Christa Buckheit Sturdevant; Lauren A Tompkins; Kathryn Twigg Arrildt; Elena Dukhovlinova; Laura P Kincer; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

Review 10.  Interplay between Wnt/β-catenin signaling and HIV: virologic and biologic consequences in the CNS.

Authors:  Lena Al-Harthi
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.